- Home
- CMPS vs RAC Comparison
CMPS vs RAC Comparison
Compare CMPS & RAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPS
- RAC
- Stock Information
- Founded
- CMPS 2020
- RAC 2024
- Country
- CMPS United Kingdom
- RAC United States
- Employees
- CMPS N/A
- RAC N/A
- Industry
- CMPS Biotechnology: Pharmaceutical Preparations
- RAC
- Sector
- CMPS Health Care
- RAC
- Exchange
- CMPS Nasdaq
- RAC Nasdaq
- Market Cap
- CMPS 364.9M
- RAC 302.3M
- IPO Year
- CMPS 2020
- RAC 2025
- Fundamental
- Price
- CMPS $4.61
- RAC $10.30
- Analyst Decision
- CMPS Strong Buy
- RAC
- Analyst Count
- CMPS 7
- RAC 0
- Target Price
- CMPS $17.00
- RAC N/A
- AVG Volume (30 Days)
- CMPS 1.8M
- RAC 115.0
- Earning Date
- CMPS 07-31-2025
- RAC 01-01-0001
- Dividend Yield
- CMPS N/A
- RAC N/A
- EPS Growth
- CMPS N/A
- RAC N/A
- EPS
- CMPS N/A
- RAC N/A
- Revenue
- CMPS N/A
- RAC N/A
- Revenue This Year
- CMPS N/A
- RAC N/A
- Revenue Next Year
- CMPS N/A
- RAC N/A
- P/E Ratio
- CMPS N/A
- RAC N/A
- Revenue Growth
- CMPS N/A
- RAC N/A
- 52 Week Low
- CMPS $2.25
- RAC $10.00
- 52 Week High
- CMPS $8.54
- RAC $10.70
- Technical
- Relative Strength Index (RSI)
- CMPS 60.45
- RAC N/A
- Support Level
- CMPS $3.97
- RAC N/A
- Resistance Level
- CMPS $4.42
- RAC N/A
- Average True Range (ATR)
- CMPS 0.22
- RAC 0.00
- MACD
- CMPS -0.01
- RAC 0.00
- Stochastic Oscillator
- CMPS 91.43
- RAC 0.00
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
About RAC Rithm Acquisition Corp. Class A Ordinary Shares
Rithm Acquisition Corp is a blank check company.